MR multispectral analysis of multiple sclerosis lesions

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 3, 1997, Pages 499-511

  Mitchell, J Ross ^a,b,c   Jones, Craig ^a,b   Karlik, Stephen J ^a,b   Kennedy, Karen ^a   Lee, Donald H ^a   Rutt, Brian ^a,b   Fenster, Aaron ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cluster classification; MR; Multiple sclerosis; Multispectral analysis; Principal components; Quantification

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPECTROSCOPY;

CALIBRATION; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MODELS, THEORETICAL; MULTIPLE SCLEROSIS; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0031397834     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070309     Document Type: Article

References (56)

1. Young IR, Hall AS. Pallis CA, Bydder GM, Legg NJ, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2:1063-1066.
2. Kesselring J, Ormerod IEC, Miller DH, du Boulay EPGH, McDonald WI. Magnetic resonance imaging in multiple sclerosis. New York: Thieme Medical Publishers, 1989; 1-93.
3. Isaac C, Li DK, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988; 38(10): 1511-1515.
4. Willowghby EW, Grochowski E, Oger J, Kastrukoff LF, Paty DF. Serial magnetic resonance scanning In multiple sclerosis: a second prospective study In relapsing patients. Ann Neurol 1989; 25:43-49.
5. Koopmans RA, Li DKB, Oger JJF, et al. Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months. Ann Neurol 1989; 26:248-256.
6. Thompson AJ, Kermode AG, MacManus DG. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990; 300:631-634.
7. Harris JO, Frank JA, Pattronas N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991; 29:548-444.
8. Weinshenker MD, Bass RN, Karlik SJ, Ebers GC, Rice GPA. An open trial of OKT3 in patients with multiple sclerosis. Neurology 1991; 41:1047.
9. Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group. Interferon beta-lb Is effective in relapsing-remitting multiple sclerosis. Neurology 1993; 43:662-667.
10. Kappos L, Stadt D, Ratzka M. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988; 30:299-302.
11. Ormerod IEC, Miller DH, McDonald WI. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987; 110:1579-1616.
12. Karlik SJ, Vandervoort MK, Hopkins M, Noseworthy JH. Serial quantitative brain MRI In multiple sclerosis using visual and volumetric techniques. Abst Neurol 1990; 40:142.
13. Pannizzo F, Stallmeyer MJB, Friedman J. Quantitative MRI studies for assessment of multiple sclerosis. Magn Reson Med 1992; 24:90-99.
14. Paty DW, Bergstrom M, Palmer M, MacFadyen J, Li D. A quantitative magnetic resonance image of the multiple sclerosis brain (abstract). Abst Neurol 1985; 35:137.
15. Gebarski SS, Gabrielsen TO, Gilman S, Knake JE, Latack JT, Aisen AM. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol 1985; 17: 469-474.
16. Arnold DL, Matthews PM, Francis G, O'Connor J, Antel J. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992; 31:235-241.
17. Wolinsky JS. Narayana PA, Fenstermacher MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990; 40(11):1764-1769.
18. Gill SS, Small RK. Thomas DG, et al. Brain metabolites as Ih NMR markers of neuronal and glial disorders. NMR Biomed 1989; 2:196-200.
19. Matthews RM, Pioro E, Narayanan S, et al. Assessment of lesion pathology In multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119:715-722.
20. Hetherington HP, Pan JW, Mason GF, et al. Quantitative 1H spectroscopic imaging of human brain at 4. IT using image segmentation. Magn Reson Med 1996; 36:21-29.
21. Grossman RI, Gormori JM, Ramer KN, Lexa FJ, Schnall MD. Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics 1994; 14:279-290.
22. Finelli DA, Hurst GC, Amantia P, Gullapali RP, Apicella A. Cerebral white matter: technical development and clinical applications of effective magnetization transfer (MT) power concepts for high-power, thin-section, quantitative MT examinationinations. Radiology 1996; 199:219-226.
23. Hiehle JF, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transer imaging In the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994; 32:285-293.
24. Tomiak MM, Rosenblum JD, Prager JM, Metz CE. Magnetiza-tion transfer a potential method to determine the age of multiple sclerosis lesions. AJNR Am J Neuroradiol 1994; 15:1569-1574.
25. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology 1995; 45:478-482.
26. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patient with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995; 196:511-515.
27. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36:632-636.
28. Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995; 16:1473-1479.
29. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RHT. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Imaging 1994; 12:33-42.
30. Morrissey SP, Stodal H, Zettl U, et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: quantification of inflammation and oedema. Brain 1996; 119:239-248.
31. Larsson HBW, Thomsen C, Freideriksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992; 10:7-12.
32. De Coene B, Hajnal JV, Pennock JM, Bydder GM. MRI of the brain stem using fluid attenuated inversion recovery pulse sequences. Neuroradiology 1993; 35:327-331.
33. Tofts P. Novel MR Image contrast mechanisms in epilepsy. Magn Reson Imaging 1995; 13(8):1099-1106.
34. Armspach J, Gounot D, Rumbach L, Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 1991; 9: 107-113.
35. MacKay A, Whittall K, Adler J, Li D. Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 1994; 31:673-677.
36. Rumbach L, Armspach JP, Gounot D, et al. Nuclear magnetic resonance T2 relaxation times in multiple sclerosis. J Neurol Sci 1991; 104:176-181.
37. Rutt BK, Mitchell JD. Myelin-selective imaging with 3-D fast spin-echo MRI (abstract). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1993. New York: Society of Magnetic Resonance In Medicine, 1993; 137.
38. Vannier MW, Butterfield RL, Jordan D, Murphy WA, Levitt RG, Gado M. Multispectral analysis of magnetic resonance images. Radiology 1985; 154:221-224.
39. Vannier MW, Butterfield RL, Rickman DL, Jordan DM, Murphy WA, Biondetti PR. Multispectral magnetic resonance Image analysis. Crit Rev Biomed Eng 1987; 15(2):117-144.
40. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson A.J. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54:683-688.
41. Kubler O, Gerig G. Segmentation and analysis of multidimensional data-sets in medicine. NATO ADI, Series F60. Berlin: Springer-Verlag, 1990; 63.
42. Gerig G, Martin J, Kikinis R, Kubler O, Shenton M, Jolesz FA. Automating segmentation of dual-echo MR head data. In: Colchester ACF, Hawkes, DJ, eds. Information processing in medical imaging, 12th international conference. London: Springer-Verlag, 1991; 175-187.
43. Kraft KA, Fatouros PP, Clarke GD, Kishore PRS. An MRI phantom material for quantitative relaxometry. Magn Reson Med 1987; 5:555-562.
44. Mitchell MD, Kundel HL, Axel L, Joseph PM. Agarose as a tissue equivalent phantom material for NMR imaging. Magn Reson Imaging 1986; 4:263-266.
45. Whittall KP, Bronskill MJ, Henkelman RM. Investigation of analysis techniques for complicated NMR relaxation data. J Magn Reson 1991; 95:221-234.
46. Mitchell JR, Karlik SJ, Lee DH, Fenster A. Computer assisted identification and quantification of multiple sclerosis lesions in MR volumes of the brain. J Magn Reson Imaging 1994; 4:197-208.
47. Mitchell JR, Karlik SJ, Lee DH, Eliasziw M, Rice GPA, Fenster A. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Med Phys 1996; 23(1):85-97.
48. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford: Blackweli Scientific Publications, 1990; 1-559.
49. Matthews WB, Compston A, Allen IV, Martyn CN. McAlpine's multiple sclerosis, 2nd ed. Edinburgh: Churchill Livingstone, 1991; 330-332.
50. Prineas JW. Multiple sclerosis: pathology of the early lesion. In: Herndon RM, Seil FJ, eds. Multiple sclerosis: current status of research and treatment. New York: Demos Publications, 1994:113-130.
51. Paty DW, Oger JJF, Koopmans RA. Willoughby EW, Stewart WA, Li DKB. Magnetic resonance studies in multiple sclerosis: diagnosis, quantification of disease burden and assessment of disease activity. In: Herndon RM, Sell FJ, eds. Multiple sclerosis: current status of research and treatment. New York: Demos Publications, 1994:131-148.
52. Stewart WA, Alvord EC Jr, Hruby S. Hall LD, Paty DW. Magnetic resonance imaging of experimental allergic encephalomyelitis in primates. Brain 1991; 114:1069-1096.
53. Fu Y, Tanaka K, Nishimura S. Evaluation of brain edema using magnetic resonance proton relaxation times. Adv Neurol 1990; 52:165-176.
54. Karlik SJ, Gilbert JJ, Wong C, Vandervoort MK, Noseworthy JH. NMR studies in experimental allergic encephalomyelitis (EAE): factors which contribute to T1 and T2 values. Magn Reson Med 1990; 14:1-11.
55. Karlik SJ, Grant EA, Lee DH, Noseworthy JH. Gadolinium enhancement in acute and chronic progressive experimental allergic encephalomyelitls in the guinea plg. Magn Reson Med 1993; 30:326-331.
56. Lacomis D, Osbakken M, Cross G. Spin-lattice relaxation (T1) times of cerebral white matter In multiple sclerosis. Magn Reson Med 1986; 3:194-202.